Effects of age and sex on piroxicam disposition

Piroxicam kinetics were studied after a single, oral, 20‐mg capsule was taken by 12 young (six women, six men) and 13 elderly (seven women, six men) healthy subjects. Plasma samples were drawn for 216 hr after dosing. Plasma protein binding was studied in vitro by equilibrium dialysis and piroxicam concentrations were measured by HPLC with ultraviolet detection. The apparent volume of distribution was smaller in elderly women (7.8 ± 0.4 l ) than in young men (11.3 ± 0.3 l ) and elderly men (10.8 ± 0.8 l ). There were no such differences when the apparent volume of distribution was normalized for total body weight. There was a strong correlation between total body weight and apparent volume of distribution in all subjects (r = 0.83). Plasma protein binding of piroxicam ranged from 98.90% to 99.54% bound and was not affected by age or sex. Piroxicam body clearance in elderly women (0.026 ± 0.002 ml/min/kg) was approximately 33% lower than in young women (0.039 ± 0.003 ml/min/kg). This difference was reflected in different t½s of 61.7 and 44.9 hr. Predicted steady‐state plasma piroxicam concentrations were 5.7 µg/ml in young women, 5.4 µg/ml in young men, 5.7 µg/ml in elderly men, and 9.3 µg/ml in elderly women. The high value in elderly women results from the lower piroxicam body clearance and total body weight. Our data suggest that healthy elderly women eliminate piroxicam at a slower rate than healthy young women. The clinical significance of these data needs to be assessed in patients. Clinical Pharmacology and Therapeutics (1985) 37, 13–18; doi: 10.1038/clpt.1985.4